SCHEMBL7028563

SCHEMBL7028563

Cc1ccc(CCCc2cc(C)ccc2S(=O)(=O)O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.42
ALOX15 P16050 1/20 0.42
TDP1 Q9NUW8 2/20 0.39
ALDH1A1 P00352 3/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
POLB P06746 2/20 0.36
RECQL P46063 2/20 0.36
FDFT1 P37268 1/20 0.36
ESR2 Q92731 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPC1 O15118 2/20 0.36
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
CASP6 P55212 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18917599 0.98 IGF1R (0.40) IGF1RALOX15TDP1ALDH1A1KMT2A
SCHEMBL30723203 0.92 GAA (0.39) TDP1ALDH1A1KMT2AMEN1POLB
SCHEMBL816601 0.92 GAA (0.39) TDP1ALDH1A1KMT2AMEN1POLB
SCHEMBL7028019 0.91 PTGES2 (0.43) IGF1RALOX15ALDH1A1KMT2AMEN1
SCHEMBL7029322 0.90 DAO (0.40) IGF1RALOX15TDP1ALDH1A1KMT2A
SCHEMBL5718625 0.89 GAA (0.39) TDP1ALDH1A1KMT2AMEN1POLB
SCHEMBL29975298 0.89 GAA (0.39) TDP1ALDH1A1KMT2AMEN1POLB
SCHEMBL18917603 0.88 TDP1 (0.40) TDP1KMT2AMEN1HTR2CHTR2B
SCHEMBL8082255 0.87 GAA (0.38) TDP1ALDH1A1KMT2AMEN1POLB
SCHEMBL8072193 0.87 GAA (0.38) TDP1ALDH1A1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042355-B1 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS SCHERING AG (DE) 2003-02-12 EP disclosed
EP-1042355-A1 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS Schering Aktiengesellschaft (DE) 2000-10-11 EP disclosed
WO-1999033855-A1 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 1999-07-08 WO disclosed